Author/Authors :
Pfaff, Sarah Department of Biomedical Imaging and Image-guided Therapy - Division of Nuclear Medicine - Medical University of Vienna - Vienna, Austria , Philippe, Cecile Department of Biomedical Imaging and Image-guided Therapy - Division of Nuclear Medicine - Medical University of Vienna - Vienna, Austria , Nics, Lukas Department of Biomedical Imaging and Image-guided Therapy - Division of Nuclear Medicine - Medical University of Vienna - Vienna, Austria , Berroteran-Infante, Neydher Department of Biomedical Imaging and Image-guided Therapy - Division of Nuclear Medicine - Medical University of Vienna - Vienna, Austria , Pallitsch, Katharina University of Vienna - Vienna, Austria , Rami-Mark, Christina Department of Biomedical Imaging and Image-guided Therapy - Division of Nuclear Medicine - Medical University of Vienna - Vienna, Austria , Weidenauer, Ana Department of Psychiatry and Psychotherapy - Division of General Psychiatry - Medical University of Vienna - Vienna, Austria , Sauerzopf, Ulrich Department of Psychiatry and Psychotherapy - Division of General Psychiatry - Medical University of Vienna - Vienna, Austria , Willeit, Matthaus Department of Psychiatry and Psychotherapy - Division of General Psychiatry - Medical University of Vienna - Vienna, Austria , Mitterhauser, Markus Department of Biomedical Imaging and Image-guided Therapy - Division of Nuclear Medicine - Medical University of Vienna - Vienna, Austria , Hacker, Marcus Department of Biomedical Imaging and Image-guided Therapy - Division of Nuclear Medicine - Medical University of Vienna - Vienna, Austria , Wadsak, Wolfgang Department of Biomedical Imaging and Image-guided Therapy - Division of Nuclear Medicine - Medical University of Vienna - Vienna, Austria , Pichler, Verena Department of Biomedical Imaging and Image-guided Therapy - Division of Nuclear Medicine - Medical University of Vienna - Vienna, Austria
Abstract :
(+)-[11C]PHNO, a dopamine D2/3 receptor agonistic radiotracer, is applied for investigating the dopaminergic system via
positron emission tomography (PET). An improved understanding of neuropsychiatric disorders associated with dysfunctions
in the dopamine system and the underlying mechanism is a necessity in order to promote the development of new potential
therapeutic drugs. In contrast to other broadly applied 11C-radiopharmaceuticals, the production of this radiotracer requires a
challenging four-step radiosynthesis involving harsh reaction conditions and reactants as well as an inert atmosphere.
Consequently, the production is prone to errors and troubleshooting after failed radiosyntheses remains time consuming.
Hence, we aimed to optimize the radiosynthesis of (+)-[11C]PHNO for achieving better activity yields without loss of product
quality. Therefore, we synthesized (+)-[11C]PHNO and omitted all heating and cooling steps leading to higher activity yields.
As a result, radiosynthesis fully conducted at room temperature led to a time-reduced production procedure that saves about
5 min, which is an appreciable decay-prevention of around 15% of the activity yield. Additionally, we established a troubleshooting protocol by investigating reaction intermediates, byproducts, and impurities. Indeed, partial runs enabled the
assignment of byproducts to their associated error source. Finally, we were able to generate a decision tree facilitating error
detection in (+)-[11C]PHNO radiosynthesis.